Sture Lindegren
Department of Radiation Physics
Sahlgrenska Academy
University of Gothenburg
Gothenburg
Sweden
Name/email consistency: high
- Direct procedure for the production of 211At-labeled antibodies with an epsilon-lysyl-3-(trimethylstannyl)benzamide immunoconjugate. Lindegren, S., Frost, S., Bäck, T., Haglund, E., Elgqvist, J., Jensen, H. J. Nucl. Med. (2008)
- (211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers. Lindegren, S., Karlsson, B., Jacobsson, L., Andersson, H., Hultborn, R., Skarnemark, G. Clin. Cancer Res. (2003)
- Synthesis and biodistribution of 211At-labeled, biotinylated, and charge-modified poly-L-lysine: evaluation for use as an effector molecule in pretargeted intraperitoneal tumor therapy. Lindegren, S., Andersson, H., Jacobsson, L., Bäck, T., Skarnemark, G., Karlsson, B. Bioconjug. Chem. (2002)
- High-efficiency astatination of antibodies using N-iodosuccinimide as the oxidising agent in labelling of N-succinimidyl 3-(trimethylstannyl)benzoate. Lindegren, S., Andersson, H., Bäck, T., Jacobsson, L., Karlsson, B., Skarnemark, G. Nucl. Med. Biol. (2001)
- Dry-distillation of astatine-211 from irradiated bismuth targets: a time-saving procedure with high recovery yields. Lindegren, S., Bäck, T., Jensen, H.J. Appl. Radiat. Isot (2001)
- Chloramine-T in high-specific-activity radioiodination of antibodies using N-succinimidyl-3-(trimethylstannyl)benzoate as an intermediate. Lindegren, S., Skarnemark, G., Jacobsson, L., Karlsson, B. Nucl. Med. Biol. (1998)
